Lexeo Therapeutics, Inc.

Nasdaq:LXEO

Biological Products, (No Diagnostic Substances)·NEW YORK, NY

Financials

10 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/5/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q/A	Q1 2025	3/31/25	5/15/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	3/24/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
↓

Earnings Releases (8-K)

10 shown

Filed	Period
11/5/25	Q4 FY2025	→
10/17/25	Q3 FY2025	→
8/14/25	Q3 FY2025	→
5/12/25	Q2 FY2025	→
3/24/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
↓

News (8-K)

20 shown

Filed	Type	Description
2/5/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/27/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/12/26	Reg FD	Regulation FD Disclosure	→
10/7/25	Reg FD	Regulation FD Disclosure	→
6/30/25	Vote	Submission of Matters to a Vote of Security Holders	→
5/27/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

37 shown

Filed	Form	Description
11/26/25	424B3	424B3	→
11/5/25	S-3	S-3	→
11/5/25	S-8	S-8	→
10/17/25	424B5	424B5	→
10/17/25	FWP	FWP	→
10/16/25	424B5	424B5	→
↓

Filing History(297 filings)

TypeDateAccessionPeriodSize

Feb 20, 2026

0002024096-26-000005

Feb 18, 2026

5.3 KB

4/A

Feb 20, 2026

0002024096-26-000004

Nov 18, 2025

5.6 KB

Feb 20, 2026

0001995218-26-000004

Feb 18, 2026

5.3 KB

144

Feb 18, 2026

0001959173-26-001161

—

5.1 KB

144

Feb 18, 2026

0001959173-26-001152

—

5.0 KB

144

Feb 18, 2026

0001959173-26-001143

—

5.1 KB

144

Feb 18, 2026

0001959173-26-001141

—

5.0 KB

144

Feb 18, 2026

0001959173-26-001140

—

5.0 KB

Feb 17, 2026

0002109299-26-000004

Feb 13, 2026

7.4 KB

SCHEDULE 13G/A

Feb 17, 2026

0001104659-26-016498

—

18.1 KB

SCHEDULE 13G/A

Feb 17, 2026

0001104659-26-016355

—

12.1 KB

SCHEDULE 13G/A

Feb 17, 2026

0001193125-26-052896

—

124.2 KB

SCHEDULE 13G/A

Feb 13, 2026

0001231919-26-000153

—

43.9 KB

Feb 6, 2026

0001995218-26-000002

Feb 4, 2026

7.5 KB

Feb 6, 2026

0002024096-26-000002

Feb 4, 2026

7.5 KB

Feb 6, 2026

0002083206-26-000002

Feb 4, 2026

7.4 KB

Feb 5, 2026

0002109299-26-000002

Jan 20, 2026

7.6 KB

8-K

Feb 5, 2026

0001193125-26-0394258-K

Jan 30, 2026

149.7 KB

SCHEDULE 13G

Jan 30, 2026

0000102909-26-000183

—

6.8 KB

SCHEDULE 13G/A

Jan 29, 2026

0001315863-26-000099

—

15.4 KB

8-K

Jan 27, 2026

0001193125-26-0233398-K

Jan 27, 2026

152.3 KB

SCHEDULE 13G

Jan 21, 2026

0002012383-26-000688

—

10.5 KB

8-K

Jan 12, 2026

0001193125-26-0100918-K

Jan 12, 2026

21.6 MB

SCHEDULE 13G/A

Dec 8, 2025

0001274173-25-000338

—

9.7 KB

EFFECT

Nov 26, 2025

9999999995-25-003406

—

1.7 KB

25 filings shown

Filed	Form	Description
6/5/25	DEFA14A	DEFA14A	→
4/28/25	DEFA14A	DEFA14A	→
4/28/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→

Lexeo Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(297 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/20/26	4	4	→
2/20/26	4/A	4/A	→
2/20/26	4	4	→
2/17/26	4	4	→
2/6/26	4	4	→
2/6/26	4	4	→
↓

Filed	Form	Description
2/18/26	144	144	→
2/18/26	144	144	→
2/18/26	144	144	→
2/18/26	144	144	→
2/18/26	144	144	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
↓